Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, Lai J, Bhattacharyya N, Israel E, Boyce JA, Laidlaw TM. Buchheit KM, et al. Among authors: laidlaw tm. J Allergy Clin Immunol. 2016 May;137(5):1566-1576.e5. doi: 10.1016/j.jaci.2015.10.020. Epub 2015 Dec 12. J Allergy Clin Immunol. 2016. PMID: 26691435 Free PMC article.
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.
Cahill KN, Katz HR, Cui J, Lai J, Kazani S, Crosby-Thompson A, Garofalo D, Castro M, Jarjour N, DiMango E, Erzurum S, Trevor JL, Shenoy K, Chinchilli VM, Wechsler ME, Laidlaw TM, Boyce JA, Israel E. Cahill KN, et al. Among authors: laidlaw tm. N Engl J Med. 2017 May 18;376(20):1911-1920. doi: 10.1056/NEJMoa1613125. N Engl J Med. 2017. PMID: 28514613 Free PMC article. Clinical Trial.
A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease.
Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, Kothari P, Raby BA, Israel E, Boyce JA. Laidlaw TM, et al. J Allergy Clin Immunol. 2019 Jan;143(1):316-324.e7. doi: 10.1016/j.jaci.2018.06.001. Epub 2018 Jun 8. J Allergy Clin Immunol. 2019. PMID: 29890239 Free PMC article. Clinical Trial.
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP. Bachert C, et al. Among authors: laidlaw tm. Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19. Lancet. 2019. PMID: 31543428 Clinical Trial.
Biologics in chronic rhinosinusitis with nasal polyposis.
Laidlaw TM, Buchheit KM. Laidlaw TM, et al. Ann Allergy Asthma Immunol. 2020 Apr;124(4):326-332. doi: 10.1016/j.anai.2019.12.001. Epub 2019 Dec 9. Ann Allergy Asthma Immunol. 2020. PMID: 31830587 Free PMC article. Review.
Chronic Rhinosinusitis with Nasal Polyps and Asthma.
Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Laidlaw TM, et al. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1133-1141. doi: 10.1016/j.jaip.2020.09.063. Epub 2020 Oct 13. J Allergy Clin Immunol Pract. 2021. PMID: 33065369 Free article.
157 results